| abstract |
The invention relates to pharmaceuticals and / or feed concentrates with antibacterial activity containing a) 2 - [(methoxycarbonylhydrazono) -methylene] -quinoxaline-1,4-dioxide optionally together with 1 or more solid and customary in medicines and / or feed concentrates / or liquid compounding agent (s) and / or 1 or more salicylic acid derivative (s), which as further active ingredient (s) b) 2- (methyl-5,7-di- (chloro) -8- (hydroxy) -quinoline {chloroquinol) and optionally c) 4-dimethylamino-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a, 5,5a, 6,11 , 12a-octahydronaphthacen-2-carboxamide {oxytetracycline} and / or d) 2,4-diamino-5- [3 ', 4', 5'-tri- (methoxy) benzyl] pyrimidine {trimethoprim}, if appropriate spatially separated division of the active ingredients in one and the same packaging or application unit. The pharmaceuticals and / or feed concentrates according to the invention are suitable for the treatment of various infections, in particular the common cold. |